Ergoteles’s CEL-SCI Corp CVM Stock Holding History

Ergoteles’s Portfolio CVM Stock Details CVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,076	Closed	-$285K	–	1536
2022 Q3	$285K	Sell	3,076 -2,275	-43%	-$274K	0.01%	1006
2022 Q2	$722K	Buy	+5,351	New	+$557K	0.02%	680

Other funds holding CVM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ergoteles's CVM Position: Q4 2022 in Review

Ergoteles sold out of CEL-SCI Corp (CVM) in Q4 2022, closing a stake of 3,076 shares — an estimated $285K sold.

Ergoteles first reported a position in CVM in Q2 2022 and held it in 2 quarters. The position peaked at $722K in Q2 2022. 75 funds tracked by Wall St. Rank hold CVM as of Q4 2022.

Ergoteles reported no remaining CEL-SCI Corp position as of Q4 2022 after selling out during the quarter.
Ergoteles sold 3,076 CEL-SCI Corp shares in Q4 2022, an estimated $285K.
Ergoteles first reported a position in CEL-SCI Corp in Q2 2022 and held it in 2 quarters.
Ergoteles's CEL-SCI Corp position peaked at $722K in Q2 2022.
75 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.